MedPath

Effect of Photodynamic Therapy on Gingival Crevicular Cytokines in Periodontitis Patients

Not Applicable
Completed
Conditions
Periodontitis, Adult
Periodontitis
Periodontal Attachment Loss
Periodontal Pocket
Interventions
Device: SRP and Fotosan 630
Registration Number
NCT03453476
Lead Sponsor
National University of Singapore
Brief Summary

Systemically healthy periodontitis patients were recruited in this single-blind, split-mouth, randomized controlled clinical trial. After SRP, PDT was applied at probing depth (PD) ≥ 4 mm at test quadrant. At baseline, 3rd month and 6th month, clinical parameters and cytokine pattern in gingival crevicular fluids (GCFs) were analysed.

Detailed Description

Periodontal parameters and cytokine IL-1β, IL-6, IL-8, TNF-α, MMP-8 levels were analysed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Adults who were medically fit or have medical condition that did not alter the outcome of periodontal treatment.
  • Females who were not pregnant or nursing.
  • Controlled diabetes mellitus with HbA1c < 7.5 mmol/L.
  • Not on any antibiotics or steroids 3 months prior to periodontal treatment.
  • Diagnosed to have either localized or generalized chronic or aggressive periodontitis (Armitage, 1999) with all 4 quadrants having at least 2 sites with probing depth ≥ 4 mm.
  • Consented to follow the non-surgical periodontal treatment (scaling and root planing) with PDT throughout the period of study, i.e. approximately 6 months.
Exclusion Criteria
  • Allergic to photosensitizer or dye
  • Pregnant lady and nursing mothers
  • Uncontrolled diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SRP and Fotosan 630SRP and Fotosan 630Scaling and root planing, photodynamic therapy using Fotosan 630
Primary Outcome Measures
NameTimeMethod
Changes from baseline clinical attachment level at 3rd month and 6th month3 months and 6 months

Clinical attachment level in mm

Changes from baseline Interleukin-8 level at 3rd month and 6th month3 months and 6 months

Interleukin-8 level in gingival crevicular fluid

Changes from baseline Matrix metalloproteinase-8 level at 3rd month and 6th month3 months and 6 months

Matrix metalloproteinase-8 level in gingival crevicular fluid

Changes from baseline bleeding score at 3rd month and 6th month3 months and 6 months

Bleeding score in percentage

Changes from baseline Interleukin-6 level at 3rd month and 6th month3 months and 6 months

Interlekin-6 level in gingival crevicular fluid

Changes from baseline Tumour necrosis factor-alpha level at 3rd month and 6th month3 months and 6 months

Tumour necrosis factor-alpha level in gingival crevicular fluid

Changes from baseline probing depth at 3rd month and 6th month3 months and 6 months

Clinical probing depth in mm

Changes from baseline gingival recession level at 3rd month and 6th month3 months and 6 months

Gingival recession level in mm

Changes from baseline Interleukin-1 level at 3rd month and 6th month3 months and 6 months

Interleukin-1 level in gingival crevicular fluid

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath